Atlas Trials

A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus

Clinical trial NCT02106364 · WITHDRAWN

Trial details

NCT number
NCT02106364
Sponsor
Eli Lilly and Company
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2015-02-01
Primary completion
2015-11-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.